Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helical CT

Richard L. Baron, James H. Oliver, Gerald D. Dodd, Michael Nalesnik, Brenda L. Holbert, Brian Carr

Research output: Contribution to journalArticlepeer-review


PURPOSE: To evaluate the added value of hepatic arterial-dominant phase (HAP) imaging to portal venous-dominant phase (PVP) imaging in patients with hepatocellular carcinoma (HCC) at computed tomography (CT). MATERIALS AND METHODS: Sixty-six patients with proved HCC underwent biphasic contrast- enhanced CT. HAP and PVP images were obtained at 20-50 and 60-100 seconds, respectively. PVP images were evaluated for the number of HCC foci. Then, HAP images were reviewed to determine whether any additional HCCs were seen. RESULTS: Three hundred twenty-six tumor loci were seen. HAP images depicted 309 foci (95%) and PVP images 268 (82%). In seven patients (11%), tumor was visible only on HAP images. During the HAP, tumors were hyperattenuating compared with liver in 26 patients, of mixed attenuation in 26, and hypoattenuating in 14 without correlation with histologic appearance. Portal vein thrombosis was identified in 17 of 21 patients on HAP images; in 12 patients, the thrombosis was diagnosed as malignant with neovascularity within the thrombus or diffuse thrombus enhancement. CONCLUSION: Use of both HAP and PVP contrast-enhanced CT optimizes the evaluation of patients with or at risk for HCC.

Original languageEnglish
Pages (from-to)505-511
Number of pages7
Issue number2
Publication statusPublished - May 1996


  • Computed tomography (CT), helical
  • Liver neoplasms
  • Liver, CT

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology


Dive into the research topics of 'Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helical CT'. Together they form a unique fingerprint.

Cite this